SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Booms, Busts, and Recoveries

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cogito Ergo Sum who wrote (51201)6/22/2004 7:35:38 PM
From: energyplay  Read Replies (3) of 74559
 
Hi Spotted - What if you had huge capital expenses, like Intel trying amortize a billion dollar semi fab over 5 years, when it's obsolete in 4 years ? Income tax allows depreciation, VAT doesn't.

What if you had massive R&D expenses, like a drug company - say Bristol-Myers Squibb, which has not had any blockbuster drugs like Lilly's Paxil or Pfizer's Lipitor to bail it out ? Essentially , they (Bristol) hit a string of dry holes. But I feel it is still worth exploring their area of expertise, which is mostly cancer drugs. No R&D deductions under VAT.

So Bristol will pay the same tax as a generic drug maker who does very little R&D.

Tax systems are matter of trading off flaws, fairness, simplicity, revenue stability, and economic effects. Trade off is such that we are luck to get half a loaf on one item, and hope the rest aren't too lousy.

I think VAT has advers economic effects, and this hurts growth. In many ways I think that the worse trade off, becaue it constrains the future.

That said, there is a lot to be said for simplicity. My 2000 IRS Form 1040 was 3/4 of an inch thick,, and on cheap laser paper. Way over 150 hours of my time.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext